$Tempus AI(TEM)$ rises against the trend, with strong growth winning market approval. AI is reshaping pharma, especially in clinical care and drug R&D. TEM starts with clinical application, demonstrating AI's substitution value to break bottlenecks, which will later feed back into R&D. Worth a long-term watch！
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
